تقدير تركيز مستضد الكاربوهيدرات 125 وعلاقة مع بعض مضادات الاكسدة في امصال دم المرضى المصابين بالعجز الكلوي

المصادر:

1. Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., et al. (2024). Chronic kidney disease and the global public health agenda: An international consensus. Nature Reviews Nephrology, 20(7), 473–485.

2. Khwaja, A. (2012). KDIGO clinical practice guidelines for acute kidney injury. Nephron Clinical Practice, 120(4), c179–c184.

3. Demsu, G., Gebru, A., Tadesse, A., Tazeb, W., Abebe, Z., Asres, R., et al. (2023). Incidence of acute kidney injury and its predictors among neonates admitted at neonatal intensive care unit, University of Gondar, Debretabor and Tibebe Ghion Amhara Region Comprehensive Specialized Hospitals, Northwest Ethiopia. BMC Pediatrics, 24, 717.

4. Rao, Z., Wang, K., Zhou, K., Duan, Y., & Zhang, Y. (2025). Global burden and epidemic trends of chronic kidney disease attributable to high body mass index: Insights from the Global Burden of Disease Study 2021. Renal Failure, 47(1), 2512400.

5. Schumacher, A. E., Kyu, H. H., Aali, A., Abbafati, C., Abbas, J., Abbasgholizadeh, R., et al. (2024). Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: A comprehensive demographic analysis. The Lancet, 403(10440), 1989–2056.

6. Borg, R., Carlson, N., Søndergaard, J., & Persson, F. (2023). The growing challenge of chronic kidney disease: An overview of current knowledge. International Journal of Nephrology, 2023, 9609266.

7. Luyckx, V. A., Tonelli, M., & Stanifer, J. W. (2018). The global burden of kidney disease and the sustainable development goals. Bulletin of the World Health Organization, 96(6), 414–422.

8. Strobeck, J. E., Feldschuh, J., & Miller, W. L. (2018). Heart failure outcomes with volume-guided management. JACC: Heart Failure, 6(11), 940–948.

9. Núñez, J., Núñez, E., Sanchis, J., Bodí, V., Fonarow, G. C., Miñana, G., et al. (2012). Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure. International Journal of Cardiology, 159(1), 21–28.

10. Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., et al. (2023). Reactive oxygen species, toxicity, oxidative stress, and antioxidants: Chronic diseases and aging. Archives of Toxicology, 97(10), 2499–2574.

11. Hadwan, M. H., & Ali, S. K. (2018). New spectrophotometric assay for assessments of catalase activity in biological samples. Analytical Biochemistry, 542, 29–33.

12. Zhang, C., Bruins, M. E., Yang, Z. Q., Liu, S. T., & Rao, P. F. (2016). A new formula to calculate activity of superoxide dismutase in indirect assays. Analytical Biochemistry, 503, 65–67.

13. Sariri, R., Sajedi, R. H., & Jafarian, V. (2006). Inhibition of horseradish peroxidase activity by thiol type inhibitors. Journal of Molecular Liquids, 123(1), 20–23.

14. You, L., Xu, Z., Liu, Q., Jin, G., & Wang, C. (2025). Tumor marker elevations in chronic kidney disease: A retrospective study. PeerJ, 13, e19240.

15. Hazra, A., Chakraborty, J., & Mandal, S. (2025). Elevated CA125 reflects disrupted albumin-sodium homeostasis in maintenance hemodialysis. European Journal of Cardiovascular Medicine, 15, 630–640.

16. Nikitiuk, B. E., Rydzewska-Rosołowska, A., Kakareko, K., Głowińska, I., & Hryszko, T. (2024). On whether CA-125 is the answer for diagnosing overhydration, particularly in end-stage kidney disease patients—A systematic review. International Journal of Molecular Sciences, 25(4), 2192.

17. Vida, C., Oliva, C., Yuste, C., Ceprián, N., Caro, P. J., Valera, G., et al. (2021). Oxidative stress in patients with advanced CKD and renal replacement therapy: The key role of peripheral blood leukocytes. Antioxidants, 10(7), 1155.

18. Hong, Y. A., & Park, C. W. (2021). Catalytic antioxidants in the kidney. Antioxidants, 10(1), 130.

19. Sagar, P., Shekhar, R., Pranay, K., Singh, P. P., & Kumar, P. (2026). Oxidant and antioxidant levels in different stages of chronic kidney disease. Cureus, 18(1).

20. Sung, C. C., Hsu, Y. C., Chen, C. C., Lin, Y. F., & Wu, C. C. (2013). Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease. Oxidative Medicine and Cellular Longevity, 2013, 301982.

21. Crawford, A., Fassett, R. G., Coombes, J. S., Kunde, D. A., Ahuja, K. D. K., Robertson, I. K., et al. (2011). Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease. Nephrology Dialysis Transplantation, 26(9), 2806–2813.

22. Yüzbaşıoğlu, Y., Hazar, M., Aydın Dilsiz, S., Yücel, C., Bulut, M., Cetinkaya, S., et al. (2024). Biomonitoring of oxidative-stress-related genotoxic damage in patients with end-stage renal disease. Toxics, 12(1), 69.